
TY  - JOUR
AU  - Marella, Mathieu
AU  - Ouyang, Joe
AU  - Zombeck, Jonathan
AU  - Zhao, Chunmei
AU  - Huang, Lei
AU  - Connor, Robert J.
AU  - Phan, Kim B.
AU  - Jorge, Michael C.
AU  - Printz, Marie A.
AU  - Paladini, Rudolph D.
AU  - Gelb, Arnold B.
AU  - Huang, Zhongdong
AU  - Frost, Gregory I.
AU  - Sugarman, Barry J.
AU  - Steinman, Lawrence
AU  - Wei, Ge
AU  - Shepard, H. Michael
AU  - Maneval, Daniel C.
AU  - Lapinskas, Paula J.
TI  - PH20 is not expressed in murine CNS and oligodendrocyte precursor cells
JO  - Annals of Clinical and Translational Neurology
JA  - Ann Clin Transl Neurol
VL  - 4
IS  - 3
SN  - 2328-9503
UR  - https://doi.org/10.1002/acn3.393
DO  - doi:10.1002/acn3.393
SP  - 191
EP  - 211
PY  - 2017
AB  - Abstract Objective Expression of Spam1/PH20 and its modulation of high/low molecular weight hyaluronan substrate have been proposed to play an important role in murine oligodendrocyte precursor cell (OPC) maturation in vitro and in normal and demyelinated central nervous system (CNS). We reexamined this using highly purified PH20. Methods Steady-state expression of mRNA in OPCs was evaluated by quantitative polymerase chain reaction; the role of PH20 in bovine testicular hyaluronidase (BTH) inhibition of OPC differentiation was explored by comparing BTH to a purified recombinant human PH20 (rHuPH20). Contaminants in commercial BTH were identified and their impact on OPC differentiation characterized. Spam1/PH20 expression in normal and demyelinated mouse CNS tissue was investigated using deep RNA sequencing and immunohistological methods with two antibodies directed against recombinant murine PH20. Results BTH, but not rHuPH20, inhibited OPC differentiation in vitro. Basic fibroblast growth factor (bFGF) was identified as a significant contaminant in BTH, and bFGF immunodepletion reversed the inhibitory effects of BTH on OPC differentiation. Spam1 mRNA was undetected in OPCs in vitro and in vivo; PH20 immunolabeling was undetected in normal and demyelinated CNS. Interpretation We were unable to detect Spam1/PH20 expression in OPCs or in normal or demyelinated CNS using the most sensitive methods currently available. Further, ?BTH? effects on OPC differentiation are not due to PH20, but may be attributable to contaminating bFGF. Our data suggest that caution be exercised when using some commercially available hyaluronidases, and reports of Spam1/PH20 morphogenic activity in the CNS may be due to contaminants in reagents.
ER  - 

TY  - JOUR
TI  - Infectious cost of leisure (Keynote lecture)
JO  - Clinical Microbiology and Infection
VL  - 7
IS  - s1
SN  - 1198-743X
UR  - https://doi.org/10.1111/j.1469-0691.2001.tb00001.x
DO  - doi:10.1111/j.1469-0691.2001.tb00001.x
SP  - 1
EP  - 357
PY  - 2001
ER  - 

TY  - JOUR
TI  - Inflammation, growth regulatory molecules & atherosclerosis
JO  - Journal of Cellular Biochemistry
JA  - J. Cell. Biochem.
VL  - 56
IS  - S18A
SN  - 0730-2312
UR  - https://doi.org/10.1002/jcb.240560509
DO  - doi:10.1002/jcb.240560509
SP  - 256
EP  - 303
PY  - 1994
ER  - 

TY  - JOUR
TI  - Abstracts from the Autumn Meeting of the Otolaryngological Research Society held on 24th September 2004 at the Institute of Laryngology and Otology, London
JO  - Clinical Otolaryngology
VL  - 30
IS  - 6
SN  - 1749-4478
UR  - https://doi.org/10.1111/j.1749-4486.2005.01110.x
DO  - doi:10.1111/j.1749-4486.2005.01110.x
SP  - 577
EP  - 582
PY  - 2005
ER  - 

TY  - JOUR
TI  - Abstract of Papers Submitted to the American Association of the Study of Liver Disease
JO  - Hepatology
JA  - Hepatology
VL  - 22
IS  - S4
SN  - 0270-9139
UR  - https://doi.org/10.1002/hep.1840220703
DO  - doi:10.1002/hep.1840220703
SP  - S107
EP  - S514
PY  - 1995
ER  - 

TY  - JOUR
TI  - ACR/ARHP scientific abstracts
JO  - Arthritis & Rheumatism
JA  - Arthritis & Rheumatism
VL  - 43
IS  - S9
SN  - 0004-3591
UR  - https://doi.org/10.1002/art.1780432007
DO  - doi:10.1002/art.1780432007
SP  - S67
EP  - S115
PY  - 2000
ER  - 

TY  - JOUR
TI  - Abstracts presented at the Annual Scientific Meeting of the Australian Rheumatology Association and the Rheumatology Health Professionals Association, 2005
JO  - Internal Medicine Journal
VL  - 35
IS  - 11
SN  - 1444-0903
UR  - https://doi.org/10.1111/j.1445-5994.2005.961.x
DO  - doi:10.1111/j.1445-5994.2005.961.x
SP  - A89
EP  - A116
PY  - 2005
ER  - 

TY  - JOUR
TI  - ORAL PRESENTATION: ATHIAL FIBRILLATION: PHYSIOLOGICAL AND PATHOPHYSIOLOGICAL FINDINGS
JO  - Pacing and Clinical Electrophysiology
VL  - 20
IS  - 5
SN  - 0147-8389
UR  - https://doi.org/10.1111/j.1540-8159.1997.tb06802.x
DO  - doi:10.1111/j.1540-8159.1997.tb06802.x
SP  - 1439
EP  - 1601
PY  - 1997
ER  - 

TY  - JOUR
AU  - Kutney, Katherine
AU  - Konczal, Laura
AU  - Kaminski, Beth
AU  - Uli, Naveen
TI  - Challenges in the diagnosis and management of disorders of sex development
JO  - Birth Defects Research Part C: Embryo Today: Reviews
JA  - Birth Defect Res C
VL  - 108
IS  - 4
SN  - 1542-975X
UR  - https://doi.org/10.1002/bdrc.21147
DO  - doi:10.1002/bdrc.21147
SP  - 293
EP  - 308
KW  - disorders of sex development
KW  - SRY
KW  - NR5A1
KW  - gonadal dysgenesis
KW  - adrenal hyperplasia
PY  - 2016
AB  - Disorders of sex development (DSD) represent a spectrum of uncommon but very complex disorders with medical, psychosexual, and family implications for those affected by them. The diagnosis and management of these disorders requires a coordinated team of multiple specialists. Following an international conference in Chicago in 2005, a consensus statement was created and presented, which has resulted in a new paradigm in the nomenclature, classification, and management of DSDs. Since that time, many improvements have been forthcoming, most notably in the area of molecular genetic technologies. These developments have advanced our understanding of the specific etiologies underlying many of these conditions. In this article, we present an overview of the physiology of sex development, a few clinical vignettes highlighting specific pathologic conditions, discussions regarding the evaluation and management of these disorders, and some thoughts on future directions in this field. Birth Defects Research (Part C) 108:293?308, 2016. ? 2016 Wiley Periodicals, Inc.
ER  - 

TY  - JOUR
TI  - Posters
JO  - FEBS Open Bio
JA  - FEBS Open Bio
VL  - 8
IS  - S1
SN  - 2211-5463
UR  - https://doi.org/10.1002/2211-5463.12453
DO  - doi:10.1002/2211-5463.12453
SP  - 105
EP  - 510
PY  - 2018
ER  - 

TY  - JOUR
TI  - RESEARCH PODIUM ABSTRACTS
JO  - Value in Health
VL  - 12
IS  - 7
SN  - 1098-3015
UR  - https://doi.org/10.1111/j.1524-4733.2009.00592_1.x
DO  - doi:10.1111/j.1524-4733.2009.00592_1.x
SP  - A221
EP  - A237
PY  - 2009
ER  - 

TY  - JOUR
TI  - POSTER SESSIONS
JO  - Allergy
VL  - 63
IS  - s88
SN  - 0105-4538
UR  - https://doi.org/10.1111/j.1398-9995.2008.01760.x
DO  - doi:10.1111/j.1398-9995.2008.01760.x
SP  - 158
EP  - 611
PY  - 2008
ER  - 

TY  - JOUR
TI  - Poster Session 3
JO  - European Journal of Heart Failure Supplements
JA  - European Journal of Heart Failure Supplements
VL  - 10
IS  - S1
SN  - 1567-4215
UR  - https://doi.org/10.1093/eurjhf/hsr007
DO  - doi:10.1093/eurjhf/hsr007
SP  - S116
EP  - S161
PY  - 2011
ER  - 

TY  - JOUR
C7  - e12328
TI  - IXA 2017- Abstracts of the 14th Congress of the International Xenotransplantation Association, Baltimore, USA
JO  - Xenotransplantation
JA  - Xenotransplantation
VL  - 24
IS  - 5
SN  - 0908-665X
UR  - https://doi.org/10.1111/xen.12328
DO  - doi:10.1111/xen.12328
SP  - e12328
PY  - 2017
ER  - 

TY  - JOUR
TI  - RESEARCH POSTER ABSTRACTS
JO  - Value in Health
VL  - 12
IS  - 7
SN  - 1098-3015
UR  - https://doi.org/10.1111/j.1524-4733.2009.00592_2.x
DO  - doi:10.1111/j.1524-4733.2009.00592_2.x
SP  - A237
EP  - A460
PY  - 2009
ER  - 

TY  - JOUR
TI  - Respiratory Nurses SIG
JO  - Respirology
VL  - 14
IS  - s1
SN  - 1323-7799
UR  - https://doi.org/10.1111/j.1440-1843.2009.01503_15.x
DO  - doi:10.1111/j.1440-1843.2009.01503_15.x
SP  - A84
EP  - A85
PY  - 2009
ER  - 

TY  - JOUR
TI  - Asthma & Allergy SIG 3 – Paediatrics, Epidemiology and Physiology
JO  - Respirology
VL  - 14
IS  - s1
SN  - 1323-7799
UR  - https://doi.org/10.1111/j.1440-1843.2009.01503_3.x
DO  - doi:10.1111/j.1440-1843.2009.01503_3.x
SP  - A43
EP  - A46
PY  - 2009
ER  - 

TY  - JOUR
TI  - Interventional Pulmonology/Lung Cancer SIGs
JO  - Respirology
VL  - 14
IS  - s1
SN  - 1323-7799
UR  - https://doi.org/10.1111/j.1440-1843.2009.01503_8.x
DO  - doi:10.1111/j.1440-1843.2009.01503_8.x
SP  - A61
EP  - A64
PY  - 2009
ER  - 

TY  - JOUR
TI  - OELD/Population Health SIGs
JO  - Respirology
VL  - 14
IS  - s1
SN  - 1323-7799
UR  - https://doi.org/10.1111/j.1440-1843.2009.01503_9.x
DO  - doi:10.1111/j.1440-1843.2009.01503_9.x
SP  - A65
EP  - A67
PY  - 2009
ER  - 

TY  - JOUR
TI  - Abstracts of Papers to be Presented at American Association of Blood Banks. 50 Annual Meeting October 18–22, 1997
JO  - Transfusion
VL  - 37
IS  - S9
SN  - 0041-1132
UR  - https://doi.org/10.1111/j.1537-2995.1997.tb02797.x
DO  - doi:10.1111/j.1537-2995.1997.tb02797.x
SP  - 1s
EP  - 111s
PY  - 1997
ER  - 
